Eastgate Biotech (OTCMKTS:ETBI) Share Price Crosses Above Fifty Day Moving Average – Time to Sell?

Eastgate Biotech Corp. (OTCMKTS:ETBI)’s stock price crossed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $0.00 and traded as high as $0.0027. Eastgate Biotech shares last traded at $0.0027, with a volume of 1,500 shares trading hands.

Eastgate Biotech Stock Down 46.0%

About Eastgate Biotech

Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions containing natural essential oils for oral administration; Glucora, a soft gelatin capsule with Banaba extract in self-emulsifying formulation for oral administration; URBAN POWER, a soft gelatin capsule with Ursolic acid and Banaba extract in self-emulsifying formulation for oral administration; Vitamin D3 nanoemulsion, a nanoemulsion with cholecalciferol; and Cleanezze, a hand sanitizer containing oil.